Caring for someone with dementia is not like caring for someone with other neurological diseases, such as advanced multiple sclerosis, organ failure, or end-stage chronic obstructive pulmonary disease (COPD). It's more like supporting someone lost in an unfamiliar world that…
Cancer Research UK reports the latest performance against cancer waiting times targets in this article.
A therapist’s gender identity can affect how counselling goes, but it depends on several things, such as the client’s background, the culture they come from, and what kind of issues they’re working on. It’s also important to remember that gender…
Researchers say ‘relatively simple, inexpensive’ means of assessing genetic risk offers hope of better screening, as outlined in an article in the Guardian "At-home saliva test for prostate cancer better than blood test, study suggests".
Cancer Research UK has published details of cancer waiting times which provides information on the latest performance against targets. See “Cancer waiting times: Latest updates and analysis”.Over the past few years, pressure on NHS cancer services has been mounting.Cancer waiting…
Heart bypass patients in Wolverhampton are set to be offered a new and less invasive treatment that also improves recovery time, NHS bosses say, as outlined in this BBC article.
Tens of thousands of UK dementia patients are to be enrolled in clinical trials designed to dramatically speed up the hunt for a cure. Read the news of this scheme in The Guardian article “Tens of thousands of UK dementia patients…
Marie Curie developed a UK-wide survey to capture public attitudes to death. Their summary report, dated October 2024, lays out the key findings. See "Public attitudes to death, dying and bereavement in the UK re-visited: 2023 survey."
More than 70 local Age UKs operate this handyperson service, which offers older people extra help with small practical jobs around the home.This article explains how it works.
Thanks to Cancer Research UK, their £1.7 million grant could give hope to patients with blood disorders such as leukaemia.The press release from University of Bristol explains Professor Linda Wooldridge’s research.